BAYES INVESTMENTS LIMITED - Accounts to registrar (filleted) - small 18.2

BAYES INVESTMENTS LIMITED - Accounts to registrar (filleted) - small 18.2


PTP Accounts Production v22.1.2.16 09325205 Board of Directors 1.1.21 31.12.21 31.12.21 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure093252052020-12-31093252052021-12-31093252052021-01-012021-12-31093252052019-12-31093252052020-01-012020-12-31093252052020-12-3109325205ns16:EnglandWales2021-01-012021-12-3109325205ns15:PoundSterling2021-01-012021-12-3109325205ns11:Director12021-01-012021-12-3109325205ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3109325205ns11:SmallEntities2021-01-012021-12-3109325205ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-3109325205ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3109325205ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3109325205ns11:FullAccounts2021-01-012021-12-3109325205ns11:OrdinaryShareClass12021-01-012021-12-3109325205ns11:Director22021-01-012021-12-3109325205ns11:CompanySecretary12021-01-012021-12-3109325205ns11:RegisteredOffice2021-01-012021-12-3109325205ns6:CurrentFinancialInstruments2021-12-3109325205ns6:CurrentFinancialInstruments2020-12-3109325205ns6:Non-currentFinancialInstruments2021-12-3109325205ns6:Non-currentFinancialInstruments2020-12-3109325205ns6:ShareCapital2021-12-3109325205ns6:ShareCapital2020-12-3109325205ns6:RetainedEarningsAccumulatedLosses2021-12-3109325205ns6:RetainedEarningsAccumulatedLosses2020-12-3109325205ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3109325205ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-3109325205ns11:OrdinaryShareClass12021-12-31
REGISTERED NUMBER: 09325205 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2021

for

BAYES INVESTMENTS LIMITED

BAYES INVESTMENTS LIMITED (Registered number: 09325205)






Contents of the Financial Statements
for the Year Ended 31 December 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BAYES INVESTMENTS LIMITED

Company Information
for the Year Ended 31 December 2021







DIRECTORS: M Fuggetta
G Manca





SECRETARY: A Rammos





REGISTERED OFFICE: 39-40 ST. JAMES'S PLACE
LONDON
SW1A 1NS





REGISTERED NUMBER: 09325205 (England and Wales)






BAYES INVESTMENTS LIMITED (Registered number: 09325205)

Balance Sheet
31 December 2021

31.12.21 31.12.20
Notes £    £   
CURRENT ASSETS
Debtors 4 367,378 7,399
Cash at bank 11,139 24,616
378,517 32,015
CREDITORS
Amounts falling due within one year 5 243,455 2,735
NET CURRENT ASSETS 135,062 29,280
TOTAL ASSETS LESS CURRENT
LIABILITIES

135,062

29,280

CREDITORS
Amounts falling due after more than
one year

6

7,111

-
NET ASSETS 127,951 29,280

CAPITAL AND RESERVES
Called up share capital 7 20,400 20,400
Retained earnings 107,551 8,880
SHAREHOLDERS' FUNDS 127,951 29,280

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BAYES INVESTMENTS LIMITED (Registered number: 09325205)

Balance Sheet - continued
31 December 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 June 2022 and were signed on its behalf by:





M Fuggetta - Director


BAYES INVESTMENTS LIMITED (Registered number: 09325205)

Notes to the Financial Statements
for the Year Ended 31 December 2021

1. STATUTORY INFORMATION

BAYES INVESTMENTS LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured as the fair value of the consideration received or receivable excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before conditions are satisfied:

* The amount of revenue can be measured reliably
* It is probable that the Company will receive the consideration due under the contract.
* The stage of completion of the contract at the end of the reporting period can be measured reliably and
* The costs incurred and the costs to complete the contract can be measured reliably.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties an investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to release the asset and settle the liability simultaneously.


BAYES INVESTMENTS LIMITED (Registered number: 09325205)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

2. ACCOUNTING POLICIES - continued
Taxation
The Tax expense for the period comprises current and deferred tax. Tax is recognised in profit and loss except that a change attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

Deferred Tax balances are recognised in respect of all timing differences that have originated but not reserved by the Balance Sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted by the balance sheet date.

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and Cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective method, less any impairment.

Interest income
Interest Income is recognised in profit and loss using the effective interest method.

Operating Leases
Leases that do not transfer all the risks and rewards of ownership are classified as operating leases. Payments under operating leases are changed to profit and loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2020 - 2 ) .

BAYES INVESTMENTS LIMITED (Registered number: 09325205)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
£    £   
Trade debtors 365,114 4,418
Other debtors 2,264 2,981
367,378 7,399

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
£    £   
Bank loans and overdrafts 889 -
Trade creditors 6,683 1,433
Taxation and social security 120,850 -
Other creditors 115,033 1,302
243,455 2,735

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.12.21 31.12.20
£    £   
Bank loans 7,111 -

7. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 31.12.21 31.12.20
value: £    £   
20,400 Ordinary £1 20,400 20,400

8. FINANCIAL COMMITMENTS, GUARANTEES AND CONTINGENCIES

The company received a Bounce Back Loan of £8,000 in May 2021. The length of the loan is 6 years, repayments begin after 12 months at a rate of 2.5% per year. There are no other financial commitments, guarantees and contingencies at 31 December 2021.